Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients with Active Cancer in a Prospective Multicenter Trial: KVTE13-01

被引：0
|
作者：
Yhim, Ho-Young
Choi, Won-Il
Kim, Sung-Hyun
Nam, Seung-Hyun
Kim, Kyoung Ha
Mun, Yeung-Chul
Hwang, Hun-Gyu
Oh, Doyeun
Lee, Keun-Wook
Song, Eun-Kee
Kwon, Yong Shik
Bang, Soo-Mee
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3711
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
    Yhim, Ho-Young
    Choi, Won-Il
    Kim, Sung-Hyun
    Nam, Seung-Hyun
    Kim, Kyoung Ha
    Mun, Yeung-Chul
    Oh, Doyeun
    Hwang, Hun-Gyu
    Lee, Keun-Wook
    Song, Eun-Kee
    Kwon, Yong Shik
    Bang, Soo-Mee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1125 - 1135
  • [2] Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers
    Lee, Jang Ho
    Lee, Joo Hee
    Jo, Kyung-Wook
    Huh, Jin-Won
    Oh, Yeon-Mok
    Lee, Jae Seung
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (01)
  • [3] The use of rivaroxaban for short- and long-term treatment of venous thromboembolism
    Cohen, Alexander T.
    Dobromirski, Mark
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1035 - 1043
  • [4] Edoxaban For Long-Term Treatment Of Venous Thromboembolism Cancer Patients
    Raskob, Gary E.
    Buller, Harry
    Angchaisuksiri, Pantep
    Oh, Doyeun
    Boda, Zoltan
    Lyons, Roger M.
    Weitz, Jeffrey I.
    Zhang, George
    Lanz, Hans J.
    Mercuri, Michele
    BLOOD, 2013, 122 (21)
  • [5] Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
    Akl, Elie A.
    Labedi, Nawman
    Barba, Maddalena
    Terrenato, Irene
    Sperati, Francesca
    Muti, Paola
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (06):
  • [6] Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Barba, Maddalena
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Sperati, Francesca
    Muti, Paola
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [7] A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer
    Lee, Jang Ho
    Hyun, Dong-gon
    Choi, Chang Min
    Lee, Jae Cheol
    Kim, Woo Sung
    Oh, Yeon-Mok
    Lee, Sang-Do
    Lee, Jae Seung
    RESPIRATION, 2019, 98 (03) : 203 - 211
  • [8] Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer The SWIss Venous ThromboEmbolism Registry (SWIVTER) II
    Spirk, David
    Ugi, Joerg
    Korte, Wolfgang
    Husmann, Marc
    Hayoz, Daniel
    Baldi, Thomas
    Frauchiger, Beat
    Banyai, Martin
    Aujesky, Drahomir
    Baumgartner, Iris
    Kucher, Nils
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 962 - 967
  • [9] Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal
    Santos, Isabel Fonseca
    Pereira, Sonia
    Mcleod, Euan
    Guillermin, Anne-Laure
    Chatzitheofilou, Ismini
    ACTA MEDICA PORTUGUESA, 2014, 27 (05): : 615 - 624
  • [10] CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
    Lee, Agnes Y. Y.
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Khorana, Alok A.
    BMC CANCER, 2013, 13
12345